Literature DB >> 1652763

Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.

M B Berkenpas1, J P Quigley.   

Abstract

Transformed cells produce elevated levels of the urokinase-type plasminogen activator (u-PA), which has been linked with the invasive or migratory phenotype of these cells. The u-PA is secreted and normally maintained in the inactive, single-chain form (scu-PA) and it has been assumed that natural activation occurs via a plasmin-mediated cleavage converting scu-PA to the active, two-chain form (tcu-PA). We now demonstrate that secreted scu-PA in Rous sarcoma virus-transformed chicken embryo fibroblast (RSVCEF) cultures is activated by an endogenous, plasmin-independent mechanism. Normal CEFs and CEFs infected with a temperature-sensitive RSV mutant and incubated at the nonpermissive temperature do not activate scu-PA. Conditioned medium harvested from plasmin-free cultures of RSVCEFs contains active tcu-PA as determined by two independent methods. The scu-PA is progressively converted with time in culture and requires the presence of intact cells or a plasma membrane-enriched fraction. When added to RSVCEF cultures, a synthetic peptide corresponding to residues 20-41 of the growth factor domain of chicken u-PA blocks the conversion to tcu-PA, and scu-PA accumulates in the cultures. These results suggest that scu-PA is secreted by cells, becomes bound to a u-PA receptor, and is proteolytically converted to active tcu-PA by a catalytic mechanism on the surface of RSV-transformed fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652763      PMCID: PMC52384          DOI: 10.1073/pnas.88.17.7768

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses.

Authors:  J P Quigley; L Ossowski; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

Review 3.  The role of proteinases in cellular invasiveness.

Authors:  D E Mullins; S T Rohrlich
Journal:  Biochim Biophys Acta       Date:  1983-12-29

4.  A proenzyme form of human urokinase.

Authors:  T C Wun; L Ossowski; E Reich
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

Review 5.  The role of urokinase-type plasminogen activator in aggressive tumor cell behavior.

Authors:  J E Testa; J P Quigley
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

6.  Phorbol ester-induced morphological changes in transformed chick fibroblasts: evidence for direct catalytic involvement of plasminogen activator.

Authors:  J P Quigley
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

7.  Serine protease and metallo protease cascade systems involved in pericellular proteolysis.

Authors:  J P Quigley; M B Berkenpas; R T Aimes; J M Chen
Journal:  Cell Differ Dev       Date:  1990-12-02

8.  Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

Authors:  L S Nielsen; J G Hansen; L Skriver; E L Wilson; K Kaltoft; J Zeuthen; K Danø
Journal:  Biochemistry       Date:  1982-12-07       Impact factor: 3.162

9.  Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells.

Authors:  J P Quigley
Journal:  J Cell Biol       Date:  1976-11       Impact factor: 10.539

10.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.

Authors:  R W Stephens; J Pöllänen; H Tapiovaara; K C Leung; P S Sim; E M Salonen; E Rønne; N Behrendt; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

View more
  2 in total

1.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.

Authors:  A M Babic; M L Kireeva; T V Kolesnikova; L F Lau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

2.  Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.

Authors:  J D Sipley; D S Alexander; J E Testa; J P Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.